Status:
TERMINATED
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Lead Sponsor:
Emory University
Collaborating Sponsors:
Georgia Institute of Technology
Conditions:
Chronic Inflammatory Demyelinating Polyneuropathy
Eligibility:
All Genders
5-21 years
Phase:
NA
Brief Summary
Participants will be requested to deliver non-invasive vagus nerve stimulation (nVNS) two times per day, at least five days per week. Participants will be followed for two years with nVNS as an adjunc...
Detailed Description
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic immune-mediated disease of the peripheral sensory motor nerves characterized by motor weakness, sensory loss, muscle wasting and l...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of CIDP based upon clinical/electrophysiological criteria
- On treatment for CIDP including IVIG and/ or steroids/plasma exchange
- Exclusion criteria:
- Inherited polyneuropathy, such as Charcot Tooth Marie disease
- Abnormal baseline EKG, heart disease, epilepsy, pregnancy, multiple sclerosis and diabetes mellitus
Exclusion
Key Trial Info
Start Date :
February 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03772717
Start Date
February 22 2022
End Date
June 30 2022
Last Update
July 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta, Center for Advanced Pediatrics
Atlanta, Georgia, United States, 30322